Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Benecke

Showing results (181-190 of 188) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 188 results.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 23, 2001
The outcome in myasthenia gravis patients--an eight-year follow-up after finishing immunoabsorption therapyJ M Schneidewind, U K Zettl, R E Winkler, et al.
Experimental Brain Research|January 19, 2000
Cutaneomotor integration in humans is somatotopically organized at various levels of the nervous system and is task dependentJ Classen, B Steinfelder, J Liepert, et al.
Brain : a Journal of Neurology|February 1, 1989
The Bereitschaftspotential is abnormal in Parkinson's diseaseJ P Dick, J C Rothwell, B L Day, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 22, 1998
What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study GroupW Poewe, G Deuschl, A Nebe, et al.
Stroke|October 7, 2000
A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after strokeA M Bakheit, A F Thilmann, A B Ward, et al.
Genomics|January 1, 1996
A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197G Auburger, T Ratzlaff, A Lunkes, et al.
Neurology|March 14, 2008
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseK Haugarvoll, R Rademakers, J M Kachergus, et al.
Journal of Neurology|December 14, 2004
Escalating immunotherapy of multiple sclerosis--new aspects and practical applicationP Rieckmann, K V Toyka, C Bassetti, et al.
Pageof 19

Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 23, 2001
The outcome in myasthenia gravis patients--an eight-year follow-up after finishing immunoabsorption therapyJ M Schneidewind, U K Zettl, R E Winkler, et al.
Experimental Brain Research|January 19, 2000
Cutaneomotor integration in humans is somatotopically organized at various levels of the nervous system and is task dependentJ Classen, B Steinfelder, J Liepert, et al.
Brain : a Journal of Neurology|February 1, 1989
The Bereitschaftspotential is abnormal in Parkinson's diseaseJ P Dick, J C Rothwell, B L Day, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 22, 1998
What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study GroupW Poewe, G Deuschl, A Nebe, et al.
Stroke|October 7, 2000
A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after strokeA M Bakheit, A F Thilmann, A B Ward, et al.
Genomics|January 1, 1996
A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197G Auburger, T Ratzlaff, A Lunkes, et al.
Neurology|March 14, 2008
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseK Haugarvoll, R Rademakers, J M Kachergus, et al.
Journal of Neurology|December 14, 2004
Escalating immunotherapy of multiple sclerosis--new aspects and practical applicationP Rieckmann, K V Toyka, C Bassetti, et al.
Pageof 19